The FDA has approved Spineart’s BAGUERA® C cervical disc for one- and two-level cervical disc replacement, giving surgeons another motion-preserving option for patients with cervical disc disease. With more than 80,000 devices sold worldwide and long-term clinical data supporting sustained motion at the treated level, the approval represents another meaningful step forward in alternatives to traditional cervical fusion.
